SCHEMBL3661234

SCHEMBL3661234

Cc1cc(N)c(O)c(CC=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
ERN1 O75460 2/20 0.39
ALOX15 P16050 2/20 0.35
HSD17B10 Q99714 2/20 0.35
AMY1A P0DUB6 1/20 0.34
HSPA5 P11021 1/20 0.34
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
HIF1A Q16665 2/20 0.33
SELL P14151 1/20 0.32
SELP P16109 1/20 0.32
SELE P16581 1/20 0.32
AKR1B10 O60218 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28418499 0.86 ERN1 (0.46) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL1347873 0.78 ALDH1A1 (0.58) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL23887046 0.78 ERN1 (0.39) ALDH1A1KDM4EERN1AMY1AHSPA5
SCHEMBL3642048 0.78 ERN1 (0.36) GAAERN1GABRA1GABRB2CA1
SCHEMBL9663590 0.76 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL1348624 0.76 AMY1A (0.57) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL4385600 0.75 TDP1 (0.48) ALDH1A1ALOX15HSD17B10SMN1; SMN2CA1
Hydrochloric Acid SCHEMBL7420110 0.73 TDP1 (0.46) ALDH1A1ALOX15HSD17B10SMN1; SMN2CA1
SCHEMBL14163474 0.72 ALDH1A1 (0.75) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL3378789 0.71 MMP2 (0.44) ALDH1A1MAPTERN1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2209790-A2 EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2010-07-28 EP disclosed
WO-2009062990-A2 EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-05-22 WO disclosed